Profile | GDS4284 / 1554229_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1521.42 | 80 |
GSM687648 | Patient 402 control | 1021.99 | 74 |
GSM687653 | Patient 403 control | 1426.75 | 79 |
GSM687658 | Patient 404 control | 516.711 | 64 |
GSM687663 | Patient 411 control | 734.636 | 69 |
GSM687668 | Patient 422 control | 1715.74 | 82 |
GSM687673 | Patient 424 control | 1035.38 | 74 |
GSM687678 | Patient 425 control | 1087.53 | 74 |
GSM687683 | Patient 427 control | 885.363 | 71 |
GSM687688 | Patient 428 control | 501.532 | 64 |
GSM687695 | Patient 441 control | 1010.57 | 75 |
GSM687699 | Patient 443 control | 475.318 | 62 |
GSM687704 | Patient 444 control | 749.309 | 70 |
GSM687707 | Patient 448 control | 938.141 | 73 |
GSM687712 | Patient 449 control | 929.559 | 73 |
GSM687719 | Patient 450 control | 680.187 | 67 |
GSM687724 | Patient 451 control | 1404.96 | 80 |
GSM687728 | Patient 452 control | 1067.26 | 75 |
GSM687646 | Patient 401 treated 24h | 1220.9 | 77 |
GSM687649 | Patient 402 treated 24h | 818.961 | 71 |
GSM687665 | Patient 411 treated 24h | 817.718 | 71 |
GSM687651 | Patient 402 treated 4 weeks | 1053.6 | 74 |
GSM687667 | Patient 411 treated 4 weeks | 1098.66 | 75 |
GSM687670 | Patient 422 treated 24h | 1523.39 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 1612.81 | 81 |
GSM687654 | Patient 403 treated 24h | 1407.98 | 79 |
GSM687675 | Patient 424 treated 24h | 1679.75 | 82 |
GSM687685 | Patient 427 treated 24h | 1349.01 | 78 |
GSM687656 | Patient 403 treated 4 weeks | 1885.32 | 83 |
GSM687677 | Patient 424 treated 4 weeks | 529.54 | 64 |
GSM687687 | Patient 427 treated 4 weeks | 1805.41 | 82 |
GSM687692 | Patient 428 treated 4h | 493.144 | 63 |
GSM687716 | Patient 449 treated 4h | 902.143 | 73 |
GSM687722 | Patient 450 treated 4h | 597.958 | 66 |
GSM687680 | Patient 425 treated 24h | 810.04 | 71 |
GSM687690 | Patient 428 treated 24h | 342.719 | 59 |
GSM687700 | Patient 443 treated 24h | 1427.44 | 79 |
GSM687705 | Patient 444 treated 24h | 366.2 | 60 |
GSM687714 | Patient 449 treated 24h | 1016.51 | 75 |
GSM687721 | Patient 450 treated 24h | 1318.29 | 78 |
GSM687682 | Patient 425 treated 4 weeks | 478.231 | 63 |
GSM687694 | Patient 428 treated 4 weeks | 600.045 | 66 |
GSM687702 | Patient 443 treated 4 weeks | 1029.98 | 74 |
GSM687718 | Patient 449 treated 4 weeks | 712.631 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 520.242 | 64 |
GSM687661 | Patient 404 treated 4h | 728.798 | 69 |
GSM687710 | Patient 448 treated 4h | 1371.32 | 79 |
GSM687726 | Patient 451 treated 4h | 1672.38 | 82 |
GSM687730 | Patient 452 treated 4h | 1265.25 | 78 |
GSM687660 | Patient 404 treated 24h | 957.793 | 75 |
GSM687697 | Patient 441 treated 24h | 986.809 | 74 |
GSM687709 | Patient 448 treated 24h | 942.317 | 74 |
GSM687725 | Patient 451 treated 24h | 1145.89 | 76 |
GSM687729 | Patient 452 treated 24h | 973.895 | 76 |
GSM687727 | Patient 451 treated 4 weeks | 1024.37 | 74 |
GSM687731 | Patient 452 treated 4 weeks | 1594.97 | 81 |